why choose us

First received: October 04, 2023

Clinical Trial: The CARDIO-TTRansform Scintigraphy Sub-study

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Study Type: OBSERVATIONAL


Official Title: CARDIO-TTRansform ION-682884-CS2-Scintigraphy Sub-study

Brief Summary: The purpose of this study is to examine the changes in amyloid myocardial burden in a subset of the population participating in the ION682884-CS2 (NCT04136171) study, up to 150 participants, after treatment with eplontersen or placebo based on scintigraphy scans performed at Week 140 using the Perugini grade score method.

Read more